title: [Current trend of glaucoma medication with various eye drops].
authors.forename: Takeo
authors.initials: T
authors.lastname: Fukuchi
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D015784:Betaxolol / Q000008:administration & dosage; D000068438:Brimonidine Tartrate; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D000077338:Latanoprost; D018696:Neuroprotective Agents; D009883:Ophthalmic Solutions; D009885:Ophthalmology / Q000639:trends*; D011453:Prostaglandins / Q000008:administration & dosage; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage; D011810:Quinoxalines / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D018696:Neuroprotective Agents; D009883:Ophthalmic Solutions; D011453:Prostaglandins; D011461:Prostaglandins F, Synthetic; D011810:Quinoxalines; D013449:Sulfonamides; D013876:Thiophenes; D000068438:Brimonidine Tartrate; D000077338:Latanoprost; C062765:dorzolamide; D015784:Betaxolol